Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Sr MD Chief Commercial Officer | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 31,561 |
Ending reported balance
After 2026-09-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-15 · Grant · Acquired 2,864 · Balance 32,974 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Row 2 · 2026-09-15 · Tax withholding · Disposed 373 · Balance 32,601 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 3 · 2026-09-15 · Tax withholding · Disposed 361 · Balance 32,240 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 4 · 2026-09-15 · Tax withholding · Disposed 320 · Balance 31,920 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 5 · 2026-09-16 · Tax withholding · Disposed 359 · Balance 31,561 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2026 Filed Sep 17, 2026 20:29 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 359 | $272.46 | $97,813.14 |
DisclosureSEC source: 0001692514-26-000003 · wk-form4_1789676963.xml · nonDerivative · entry 5 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,561 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:29 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 320 | $275.09 | $88,028.80 |
DisclosureSEC source: 0001692514-26-000003 · wk-form4_1789676963.xml · nonDerivative · entry 4 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,920 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:29 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 361 | $275.09 | $99,307.49 |
DisclosureSEC source: 0001692514-26-000003 · wk-form4_1789676963.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,240 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:29 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 373 | $275.09 | $102,608.57 |
DisclosureSEC source: 0001692514-26-000003 · wk-form4_1789676963.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,601 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:29 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,864 | $275.09 | $787,857.76 |
DisclosureSEC source: 0001692514-26-000003 · wk-form4_1789676963.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,974 F1 · kind: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 3,658 | $311.40 | $1,139,101.20 |
DisclosureSEC source: 0001628280-26-018539 · wk-form4_1773764613.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,110 F2 · shares: Ms. Winkler surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 8,256 | $311.40 | $2,570,918.40 |
DisclosureSEC source: 0001628280-26-018539 · wk-form4_1773764613.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,768 F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. Read SEC document |
| September 16, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 379 | $259.83 | $98,475.57 |
DisclosureSEC source: 0001692514-25-000005 · wk-form4_1758131357.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,512 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,044 | $258.83 | $787,878.52 |
DisclosureSEC source: 0001692514-25-000005 · wk-form4_1758131357.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,891 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,081 | $258.83 | $279,795.23 |
DisclosureSEC source: 0001692514-25-000005 · wk-form4_1758131357.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,847 F1 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:18 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,625 | $258.68 | $420,355.00 |
DisclosureSEC source: 0001156375-25-000048 · wk-form4_1742314683.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,928 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:18 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,668 | $258.68 | $948,838.24 |
DisclosureSEC source: 0001156375-25-000048 · wk-form4_1742314683.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,553 F1 · shares: For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 14:02 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 11,592 | $249.17 | $2,888,378.64 |
DisclosureSEC source: 0001156375-25-000011 · wk-form4_1739541757.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,885 F1 · shares: On February 13, 2025, Ms. Winkler sold an aggregate of 11,592 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $249.11 to $249.34. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 23:10 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,604 | $218.53 | $787,582.12 |
DisclosureSEC source: 0001156375-24-000171 · wk-form4_1726614625.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,477 Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 23:10 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,467 | $216.99 | $318,324.33 |
DisclosureSEC source: 0001156375-24-000171 · wk-form4_1726614625.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,873 F1 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,847 | $217.50 | $619,222.50 |
DisclosureSEC source: 0001156375-24-000047 · wk-form4_1710861822.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,340 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,425 | $217.50 | $1,397,437.50 |
DisclosureSEC source: 0001156375-24-000047 · wk-form4_1710861822.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,187 F1 · shares: Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023. Read SEC document |
| September 16, 2023 Filed Sep 18, 2023 22:09 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 284 | $206.82 | $58,736.88 |
DisclosureSEC source: 0001156375-23-000152 · wk-form4_1695074983.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,762 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2023. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:09 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,135 | $206.82 | $234,740.70 |
DisclosureSEC source: 0001156375-23-000152 · wk-form4_1695074983.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,046 F1 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2023. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:09 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,808 | $206.82 | $787,570.56 |
DisclosureSEC source: 0001156375-23-000152 · wk-form4_1695074983.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,181 Read SEC document |
| August 10, 2023 Filed Aug 11, 2023 14:19 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 6,262 | $207.00 | $1,296,234.00 |
DisclosureSEC source: 0001156375-23-000135 · wf-form4_169176355104351.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,373 Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:05 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 299 | $191.56 | $57,276.44 |
DisclosureSEC source: 0001156375-22-000285 · wf-form4_166362872387126.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,635 F2 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:05 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000285 · wf-form4_166362872387126.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,934 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:05 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 740 | $190.77 | $141,169.80 |
DisclosureSEC source: 0001156375-22-000285 · wf-form4_166362872387126.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,806 F1 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2022. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 21:50 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000241 · wf-form4_166327858922332.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,546 F1 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. Read SEC document |
| September 14, 2022 Filed Sep 19, 2022 23:11 UTC Amendment | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 304 | $191.30 | $58,155.20 |
DisclosureSEC source: 0001156375-22-000298 · wf-form4a_166362907039260.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,546 F1 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. F2 · price: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 749 | $232.00 | $173,768.00 |
DisclosureSEC source: 0001156375-22-000130 · wf-form4_164754975701614.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,850 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:43 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,243 | $232.00 | $520,376.00 |
DisclosureSEC source: 0001156375-22-000130 · wf-form4_164754975701614.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,599 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 19:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 315 | $188.69 | $59,437.35 |
DisclosureSEC source: 0001156375-21-000151 · wf-form4_163190707138898.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,356 F1 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-21-000123 · wf-form4_163181125719977.xml · nonDerivative · entry 4 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,671 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 404 | $188.96 | $76,339.84 |
DisclosureSEC source: 0001156375-21-000123 · wf-form4_163181125719977.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,299 F2 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 376 | $188.96 | $71,048.96 |
DisclosureSEC source: 0001156375-21-000123 · wf-form4_163181125719977.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,703 F2 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2021. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 321 | $188.85 | $60,620.85 |
DisclosureSEC source: 0001156375-21-000123 · wf-form4_163181125719977.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,079 F1 · shares: Ms. Julie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2021. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,500 | $217.00 | $759,500.00 |
DisclosureSEC source: 0001156375-21-000057 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,400 Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:27 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 99 | $209.09 | $20,699.91 |
DisclosureSEC source: 0001156375-21-000039 · edgardoc.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,900 F3 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2021. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:27 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,500 | $209.09 | $522,725.00 |
DisclosureSEC source: 0001156375-21-000039 · edgardoc.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,999 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:27 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,578 | $209.09 | $1,375,394.02 |
DisclosureSEC source: 0001156375-21-000039 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,499 F1 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2018-2020. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 23:07 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,059 | $181.02 | $734,760.18 |
DisclosureSEC source: 0001156375-20-000127 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,921 F1 · price: On December 14, 2020, Ms. Winkler sold an aggregate of 4,059 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $181.00 to $181.07. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 22:03 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 327 | $170.20 | $55,655.40 |
DisclosureSEC source: 0001156375-20-000112 · edgardoc.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,980 F1 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 388 | $168.10 | $65,222.80 |
DisclosureSEC source: 0001156375-20-000099 · edgardoc.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,515 F2 · shares: Ms. Julie Marie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 189 | $168.10 | $31,770.90 |
DisclosureSEC source: 0001156375-20-000099 · edgardoc.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,903 F2 · shares: Ms. Julie Marie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:03 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000112 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,307 Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 01:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 332 | $166.08 | $55,138.56 |
DisclosureSEC source: 0001156375-20-000099 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,092 F1 · shares: Ms. Julie Marie Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2020. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 178 | $182.01 | $32,397.78 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 9 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,424 F4 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/20. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 802 | $182.01 | $145,972.02 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 8 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,602 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 7 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,404 F3 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 802 | $182.01 | $145,972.02 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 6 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,594 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 5 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,396 F3 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 909 | $182.01 | $165,447.09 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 4 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,586 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,495 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.